Information  X 
Enter a valid email address

BBGI SICAV S.A (BBGI)

  Print      Mail a friend

Thursday 25 October, 2018

BBGI SICAV S.A

Director/PDMR Shareholding

RNS Number : 2346F
BBGI SICAV S.A.
25 October 2018
 

25 October 2018

BBGI SICAV S.A.

   

Director / PDMR Shareholding

1.

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Colin Maltby

2.

Reason for the notification

a.

Position / Status

Chairman of Supervisory Board

b.

Initial Notification / Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

BBGI SICAV S.A.

b.

LEI

5299 00CV 0RWC OP5Y HK95

4.

Details of the transaction(s):

[section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted]

a.

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares - No Par Value

 

ISIN - LU0686550053

b.

Nature of the transaction

Acquisition of Shares pursuant to Scrip Dividend Alternative

c.

Price(s) and volume(s)

Price

Volume

Total

£1.4478

2,797

£4,049.50

d.

Aggregated information

 

- Aggregated volume

- Price

-Total Value

As in 4 c) above

e.

Date of the transaction

24 October 2018

f.

Place of the transaction

London Stock Exchange

 

Director / PDMR Shareholding

1.

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Duncan Ball

2.

Reason for the notification

a.

Position / Status

Management Board Director / Co-CEO

b.

Initial Notification / Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

BBGI SICAV S.A.

b.

LEI

5299 00CV 0RWC OP5Y HK95

4.

Details of the transaction(s):

[section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted]

a.

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares - No Par Value

 

ISIN - LU0686550053

b.

Nature of the transaction

Acquisition of Shares pursuant to Scrip Dividend Alternative

c.

Price(s) and volume(s)

Price

Volume

Total

£1.4478

9,760

£14,130.53

d.

Aggregated information

 

- Aggregated volume

- Price

-Total Value

As in 4 c) above

e.

Date of the transaction

24 October 2018

f.

Place of the transaction

London Stock Exchange

 

Director / PDMR Shareholding

1.

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Michael Denny

2.

Reason for the notification

a.

Position / Status

Management Board Director / CFO

b.

Initial Notification / Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

BBGI SICAV S.A.

b.

LEI

5299 00CV 0RWC OP5Y HK95

4.

Details of the transaction(s):

[section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted]

a.

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares - No Par Value

 

ISIN - LU0686550053

b.

Nature of the transaction

Acquisition of Shares pursuant to Scrip Dividend Alternative

c.

Price(s) and volume(s)

Price

Volume

Total

£1.4478

1,801

£2,607.49

d.

Aggregated information

 

- Aggregated volume

- Price

-Total Value

As in 4 c) above

e.

Date of the transaction

24 October 2018

f.

Place of the transaction

London Stock Exchange

 

 

For further information, please contact:

 

BBGI SICAV S.A.       +352 26 34 79-1

Duncan Ball

Frank Schramm

 

 

 

END

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHMABATMBBTBMP

a d v e r t i s e m e n t